All lobbying filings

MAGILL ASSOCIATES, LLC

MAGILL ASSOCIATES, LLC filed a Q3 report for THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES on October 1, 2026.

Lobbying for THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES · Government and public relations consultants

All filings by MAGILL ASSOCIATES, LLC · Everything THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 1, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

JOHN PIERSON MAGILL

Previously held: COS to Rep. Wally Herger

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

FY 2027 appropriations for the development of a synthetic vaccine

Medical/Disease Research/Clinical Labs

FY 2027 appropriations for the development of a synthetic vaccine

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.